Legitimate pain research is more crucial than ever
Researchers today say opioids are not only dangerous; they are not a good long-term solution for chronic pain sufferers. The relief tends to wane with time.
Even with delta surging, experts say two vaccine doses is enough for now
U.S. firm Pfizer Inc. has called for an additional third shot of its COVID-19 vaccine, citing new data showing its efficacy tails off after six months.
How behavioral economics views mask mandates
What we know from behavioral economics suggests that universal mask requirements will undermine the effort to get as many people as possible vaccinated.
The system, which would allow workers up to 10 days additional leave to undergo treatment, would be separate from annual and sick leave.
Doctors blast Biogen Alzheimer approval as ‘regulatory failure’
The New England Journal of Medicine opinion piece is another sign of persistent furor over the agency’s decision.
London’s delta surge should jolt New York
A big question is whether New York, another large city that has reopened after having been through the COVID-19 wringer in 2020, will face a similar resurgence of cases like London.
Medical workers and relatives of COVID-19 victims worried about Olympics
Cases have been reported among athletes and officials, including people staying at the Olympic Village in Tokyo.
At this point, the U.K.'s COVID-19 rules follow politics as much as science
If the last 18 months have taught us anything, it’s that a successful COVID-19 policy requires three things: high levels of public trust, a coherent strategy and effective implementation.
As delta variant rages in Southeast Asia, health workers warned not to speak out
In Southeast Asian nations, health care providers calling for stronger job security and better protection against variants of the coronavirus, have put governments on the defensive.
With the number of people who agree to donate their skin after death on the decline, the Japan Skin Bank Network is calling for cooperation from citizens.
World carved up into haves and have-nots by mRNA vaccine access
The cutting-edge technology, which made its debut during the pandemic, has proven more effective than any other in staving off infections and serious illness from the coronavirus.
Patients with intractable diseases facing labor issues in Japan
Some people with rare or incurable conditions are calling for better systems to help them balance their work with their illness.
